Induction of DC-STAMP by Alternative Activation and Downstream Signaling Mechanisms
Mitsuru Yagi(Keio University), Takeshi Miyamoto(Kumamoto Health Science University), Nobuyuki Fujita(Fujita Health University), Toshio Suda(Chinese Academy of Sciences), Kozo Morita(Tokyo Women's Medical University), Ken Ninomiya(Kawasaki Hospital), T. Suzuki, Naobumi Hosogane(Keio University), Yoshiaki Toyama(Keio University), Ryotaro Iwasaki(Keio University), Koichi Matsuo(Hiroshima University)
Cited by 139
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694